✦ LIBER ✦
P-49 Phase II study of epirubicin in combination with weekly taxotere for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy
✍ Scribed by Chang, John W.C.; Tsao, Thomas C.Y.; Chen, Chih-Hung; Tsai, Ying-Hwang; Lin, Meng-Chi; Lin, Chi-Ming
- Book ID
- 118571750
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 169 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.